These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Histamine liberation in surgical patients following administration of neuromuscular blocking drugs. Ertama PM Ann Clin Res; 1982 Feb; 14(1):15-26. PubMed ID: 6182834 [TBL] [Abstract][Full Text] [Related]
24. Acute and chronic changes in intra- and extracellular potassium and responses to neuromuscular blocking agents. Hill GE; Wong KC; Shaw CL; Blatnick RA Anesth Analg; 1978; 57(4):417-21. PubMed ID: 568402 [TBL] [Abstract][Full Text] [Related]
25. Neuromuscular block: atracurium and vecuronium compared and combined. Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032 [TBL] [Abstract][Full Text] [Related]
26. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347 [TBL] [Abstract][Full Text] [Related]
27. Applied pharmacology of common neuromuscular blocking agents in critical care. Prielipp RC; Coursin DB New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428 [TBL] [Abstract][Full Text] [Related]
29. [Analysis of blocking action of dimethyl dl-curine dimethochloride on neuromuscular transmission (author's transl)]. Yang QZ; Lin LR; Tang XC Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):87-90. PubMed ID: 6287804 [No Abstract] [Full Text] [Related]
30. Interactions of neuromuscular blocking drugs. Cammu G Acta Anaesthesiol Belg; 2001; 52(4):357-63. PubMed ID: 11799568 [TBL] [Abstract][Full Text] [Related]
31. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs. Booij LH; Edwards RP; Sohn YJ; Miller RD Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662 [TBL] [Abstract][Full Text] [Related]
32. Neuromuscular relaxation and reversal: an update. Walker JR J Perianesth Nurs; 1997 Aug; 12(4):264-74. PubMed ID: 9287638 [TBL] [Abstract][Full Text] [Related]
33. The interaction of hexafluorenium with other neuromuscular blocking agents in man. Foldes FF Anaesthesist; 1966 Mar; 15(3):75-8. PubMed ID: 4383609 [No Abstract] [Full Text] [Related]
34. Potentiation of neuromuscular blockade in man produced by combinations of pancuronium and metocurine or pancuronium and d-tubocurarine. Lebowitz PW; Ramsey FM; Savarese JJ; Ali HH Anesth Analg; 1980 Aug; 59(8):604-9. PubMed ID: 7190795 [TBL] [Abstract][Full Text] [Related]
35. Differential increase in potency of neuromuscular blocking agents by enflurane and halothane. Schuh FT Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):383-6. PubMed ID: 6629542 [TBL] [Abstract][Full Text] [Related]
36. [Interaction of d-tubocurarine and pancuronium on neuromuscular transmission in man]. Yang CY; Ho ST; Lin C; Chang CL Ma Zui Xue Za Zhi; 1986 Jun; 24(2):105-10. PubMed ID: 3023782 [No Abstract] [Full Text] [Related]
37. Residual neuromuscular blockade in critical care. Wilson J; Collins AS; Rowan BO Crit Care Nurse; 2012 Jun; 32(3):e1-9; quiz e10. PubMed ID: 22661165 [TBL] [Abstract][Full Text] [Related]
38. The effects of roxatidine on neuromuscular transmission. Bossa R; Chiericozzi M; Galatulas I; Salvatore G; Teli M; Baggio G; Castelli M In Vivo; 1995; 9(2):113-5. PubMed ID: 7548786 [TBL] [Abstract][Full Text] [Related]
39. Practical points in understanding neuromuscular blockade. Steckbar T J Post Anesth Nurs; 1990 Oct; 5(5):350-3. PubMed ID: 2213630 [TBL] [Abstract][Full Text] [Related]